P1.14-05 TP53 Exon 8 Mutation and Prognosis in EGFR-Mutated NSCLC Patients Treated with First-And-Second-Generation TKIs

Autor: Canale, M., Petracci, E., Crino, L., De Luigi, N., Ludovini, V., Dubini, A., Baglivo, S., Minenza, E., Chiadini, E., Landi, L., Papi, M., Delmonte, A., Bronte, G., Ulivi, P.
Zdroj: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S553-S554
Databáze: ScienceDirect